Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryam Keshvari

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Diabetology & Metabolic Syndrome|May 27, 2021
Exercise training and de-training effects on serum leptin and TNF-α in high fat induced diabetic ratsHamideh Dinari Ghozhdi, Ali Heidarianpour, Maryam Keshvari, et al.
Human Vaccines|April 10, 2008
Predicting response to HBV vaccination in people with positive anti-HBc but negative HBsAg and anti-HBsAli Kabir, Maryam Keshvari, Amir Hossein Faghihi Kashani, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 21, 2015
Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013Maryam Keshvari, Heidar Sharafi, Seyed Moayed Alavian, et al.
Hepatitis Monthly|October 28, 2015
Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis CMahdiyar Pouresmaeeli, Seyed Moayed Alavian, Maryam Keshvari, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|December 2, 2016
The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis CMaryam Keshvari, Seyed Moayed Alavian, Bita Behnava, et al.
Hepatitis Monthly|November 25, 2014
The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control StudyHeidar Sharafi, Seyed Moayed Alavian, Bita Behnava, et al.
Pathogens (Basel, Switzerland)|April 28, 2023
Trends in the Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Iranian Patients with Hereditary Bleeding DisordersAzar Gharoonpour, Saeideh Maleki, Hamid Sharifi, et al.
Hepatitis Monthly|April 19, 2014
Interferon alpha-2b therapy in chronic hepatitis deltaMaryam Keshvari, Seyed Moayed Alavian, Heidar Sharafi, et al.
World Journal of Gastroenterology|August 14, 2015
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patientsArghavan Haj-Sheykholeslami, Maryam Keshvari, Heidar Sharafi, et al.
Laboratory Medicine|January 7, 2017
A Simple PCR-RFLP Method for Genotyping of IFNL4 rs368234815 Polymorphism in Patients With Chronic Hepatitis CMohammad Pouryasin, Heidar Sharafi, Bita Behnava, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Diabetology & Metabolic Syndrome|May 27, 2021
Exercise training and de-training effects on serum leptin and TNF-α in high fat induced diabetic ratsHamideh Dinari Ghozhdi, Ali Heidarianpour, Maryam Keshvari, et al.
Human Vaccines|April 10, 2008
Predicting response to HBV vaccination in people with positive anti-HBc but negative HBsAg and anti-HBsAli Kabir, Maryam Keshvari, Amir Hossein Faghihi Kashani, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 21, 2015
Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013Maryam Keshvari, Heidar Sharafi, Seyed Moayed Alavian, et al.
Hepatitis Monthly|October 28, 2015
Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis CMahdiyar Pouresmaeeli, Seyed Moayed Alavian, Maryam Keshvari, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|December 2, 2016
The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis CMaryam Keshvari, Seyed Moayed Alavian, Bita Behnava, et al.
Hepatitis Monthly|November 25, 2014
The Impact of IFNL4 rs12979860 Polymorphism on Spontaneous Clearance of Hepatitis C; A Case-Control StudyHeidar Sharafi, Seyed Moayed Alavian, Bita Behnava, et al.
Pathogens (Basel, Switzerland)|April 28, 2023
Trends in the Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Iranian Patients with Hereditary Bleeding DisordersAzar Gharoonpour, Saeideh Maleki, Hamid Sharifi, et al.
Hepatitis Monthly|April 19, 2014
Interferon alpha-2b therapy in chronic hepatitis deltaMaryam Keshvari, Seyed Moayed Alavian, Heidar Sharafi, et al.
World Journal of Gastroenterology|August 14, 2015
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patientsArghavan Haj-Sheykholeslami, Maryam Keshvari, Heidar Sharafi, et al.
Laboratory Medicine|January 7, 2017
A Simple PCR-RFLP Method for Genotyping of IFNL4 rs368234815 Polymorphism in Patients With Chronic Hepatitis CMohammad Pouryasin, Heidar Sharafi, Bita Behnava, et al.
Pageof 5